We are updating the design of this site. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Interval Training and Resting Metabolism (NEAT)

This study has been completed.
Sponsor:
ClinicalTrials.gov Identifier:
NCT01313468
First Posted: March 11, 2011
Last Update Posted: March 30, 2017
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Collaborator:
St. Olavs Hospital
Information provided by (Responsible Party):
Norwegian University of Science and Technology
March 10, 2011
March 11, 2011
March 30, 2017
February 2011
November 2011   (Final data collection date for primary outcome measure)
nonexercise activity thermogenesis [ Time Frame: Baseline and 10 weeks ]
NEAT Will be measured using an activity sensor. Physical activity is recorded over a 7 day period. The energy equivalent of each of these activities is determined. The time spent in each activity is then multiplied by equivalent for the activity. The values are then summed to derive an estimate of NEAT.
Same as current
Complete list of historical versions of study NCT01313468 on ClinicalTrials.gov Archive Site
Cardiopulmonary maximal oxygen uptake [ Time Frame: Baseline and 10 weeks ]
The secondary aims are to investigate the changes in maximal oxygen uptake, heart function, and body composition in response to interval training
Same as current
Not Provided
Not Provided
 
Interval Training and Resting Metabolism
Effect of Aerobic Interval Training on NEAT in Sedentary Men

It has been reported that obese individuals are seated 2 ½ hour more than lean individuals and that non exercise thermo genesis (NEAT) may vary with as much as 2000 Kcal/day between equal size people due to different occupational and leisure time activities. The primary aim of the study is to investigate if 10 weeks of exercise training increase NEAT in sedentary men.

Subject will be randomized to three different training intervention, with 3 exercise session each week for 10 weeks. NEAT will be measured using an activity sensor and recorded over a 7 day period both before and after training.

Not Provided
Interventional
Not Provided
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Single (Investigator)
Primary Purpose: Prevention
Healthy Subjects
  • Behavioral: 1 x 4 minute interval
    1 x 4 minutes of high intensity intervals at 90-95% of maximal heart rate
  • Behavioral: 4 x 4 minutes Intervals
    4 x 4 minutes of high intensity intervals at 90-95% of maximal heart rate separated by 3 minutes of active brakes in between at 70% of maximal heart rate.
  • Behavioral: Moderate continuous Training
    47 minutes of Moderate continuous Training
  • Experimental: 4 x 4 Interval
    4 x 4 minutes of high intensity intervals at 90-95% of maximal heart rate separated by 3 minutes of active brakes in between at 70% of maximal heart rate.
    Intervention: Behavioral: 4 x 4 minutes Intervals
  • Experimental: 1 4 minutes interval
    1 x 4 minutes intervals at 90-95% of HR max
    Intervention: Behavioral: 1 x 4 minute interval
  • Experimental: Moderate continuous Training
    47 minutes of Moderate continuous Training
    Intervention: Behavioral: Moderate continuous Training
Zisko N, Stensvold D, Hordnes-Slagsvold K, Rognmo Ø, Nauman J, Wisløff U, Karlsen T. Effect of Change in VO2max on Daily Total Energy Expenditure in a Cohort of Norwegian Men: A Randomized Pilot Study. Open Cardiovasc Med J. 2015 Apr 30;9:50-7. doi: 10.2174/1874192401509010050. eCollection 2015.

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Completed
30
November 2011
November 2011   (Final data collection date for primary outcome measure)

Inclusion Criteria:

  • Male gender
  • Age 18-50
  • BMI 25-30 kg x m2
  • No significant comorbidities
  • Abel to exercise
  • Not partaking in organized physical activity

Exclusion Criteria:

  • Inability to exercise due to musculoskeletal conditions
  • Known ischemic cardiovascular disease
  • High daily physical and occupational activity levels
Sexes Eligible for Study: Male
18 Years to 50 Years   (Adult)
Yes
Contact information is only displayed when the study is recruiting subjects
Norway
 
 
NCT01313468
2010/1541
No
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No
Plan to Share IPD: No
Norwegian University of Science and Technology
Norwegian University of Science and Technology
St. Olavs Hospital
Principal Investigator: Trine Karlsen NTNU
Norwegian University of Science and Technology
March 2017

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP